Neurolens Partners with University of Montreal’s Clinique Universitaire de la Vision
Tuesday, March 22 2022 | 14 h 23 min | News
To fuel continued growth, Neurolens continues to invest heavily into developing new technologies and clinical research initiatives. A key driver of these initiatives is partnerships with leading schools of optometry such as the École d’optométrie de l’Université de Montréal. The two organizations will partner on several collaborative projects intended to define future product line enhancements and conceptualize product innovations, particularly in myopia control.
“We are thrilled and honored to partner with an institution with a well-known reputation for innovation like the École d’optométrie de l’Université de Montréal,” said Pierre Bertrand, CEO of Neurolens. “We are announcing a major donation of a 2nd generation Neurolens measuring device (NMD2) to the Clinique Universitaire de la Vision. This exciting partnership will help us define our innovation roadmap for years to come, and allow us to drive even more life-changing patient outcomes.”
“According to Dr. Langis Michaud, Optometrist and Director of the School of Optometry, “Innovation is in the DNA of our School. Considering the rapid changes we are subjected to, it is important to use the latest technology to help diagnose and treat visual anomalies. Neurolens’ major donation opens doors to innovative technologies that will benefit our patients. In addition, by developing a research partnership, we will be able to pool our strengths and develop products that will meet the visual needs of this technological age where children’s eyes are under great strain. We are excited to partner with Neurolens to fuel that will allow the industry to continue to adapt to the changing needs of patients worldwide.”
Click HERE for the full press release.
